Xiaobing Wang

Nov 6, 2024 | mdpi.com | Zhiqi Xu |Jintao Zhang |Xiaobing Wang |Sijiang Zhang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Oct 9, 2024 | onlinelibrary.wiley.com | Qi Zhang |Tengfei Bian |Xiaobing Wang |Ruijuan Shi

Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Sep 22, 2024 | nature.com | Yucheng Jiao |Xiaobing Wang |Jianming Ying

Abstract Liver metastasis remains the primary cause of mortality in patients with colon cancer. Identifying specific driver gene mutations that contribute to metastasis may offer viable therapeutic targets. To explore clonal evolution and genetic heterogeneity within the metastasis, we conducted single-cell exome sequencing on 150 single cells isolated from the primary tumor, liver metastasis, and lymphatic metastasis from a stage IV colon cancer patient.

Jul 15, 2024 | cell.com | Xiaobing Wang |Xin Wu |Binghe Tan |Liang Zhu

National Institutes of HealthAutoimmune Diseases Coordinating CommitteeAutoimmune Diseases Coordinating Committee: Progress in Autoimmune Diseases Research. United States Department of Health and Human Services, 2005Fugger L. Jensen L.T. Rossjohn J. Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases. Cell. 2020; 181: 63-80https://doi.org/10.1016/j.cell.2020.03.007Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts. Front. Immunol.

Jul 3, 2024 | onlinelibrary.wiley.com | Linrui Duan |Siyu Liu |Xiaobing Wang |Zhuang Zhang

1 Introduction Organic–inorganic hybrid perovskite solar cells (PSCs) have garnered considerable attention in the photovoltaic industry due to their cost-effective production and outstanding optoelectronic properties.[1-5] Over the past decade, PSC technology has achieved a remarkable breakthrough in power conversion efficiency (PCE) of 26.1%, comparable to the highest-performing single-crystalline solar cells. These advancements position PSCs as having significant commercial potential.